Zhuo Yunhui, Hepatitis Department of Shanghai Shuguang Hospital East: For hepatitis B patients, first of all, we should take a scientific attitude and recognize the characteristics of the disease, which is a chronic disease that requires long-term treatment. Secondly, it is very important to adhere to long-term effective antiviral therapy to suppress the virus in the treatment of hepatitis B. You cannot stop or reduce the dosage without authorization. Can not stop or reduce the amount of medication without authorization. Thirdly, it is important to treat the disease correctly, and it is very beneficial to have a healthy mental state. Being sad and tense all day long will be detrimental to the recovery of the disease. Fourth, we should consult with a specialist if we have any problems, and never just read some incorrect propaganda in the media. Nowadays, many medicines have not been scientifically verified and approved by the state. There are traditional Chinese medicines as well as western medicines, which have not proved their effective therapeutic effects, so don’t use these medicines casually. There are two types of antiviral drugs, interferon (including long-acting interferon) and nucleoside (acid) analogs. There are advantages and disadvantages to both types of drugs. You are 55 years old, or consider nucleoside (acid) analogs. There are four nucleoside (acid) analogs that have been approved both domestically and internationally, one is lamivudine, which is used more often and was the first nucleoside analog to be applied, followed by adefovir, the third is entecavir (Boludin), and the fourth drug is tibivudine (Surbivudine). Early viral efficacy predicts good or poor subsequent efficacy, as well as the incidence of drug resistance. At 24 weeks of treatment, the level of HBVDNA can predict the efficacy of the treatment, the efficacy of the treatment can be continued, the efficacy of the treatment is not good, you can change the Q and add other antiviral drugs, so in addition to predicting the efficacy of the treatment, predicting the rate of resistance to the drug, you can decide on the next step in the individualization of the treatment regimen.